KLRB1
KLRB1 (killer cell lectin like receptor B1), also known as CD161 and NKR-P1A, is a C-type lectin-like membrane receptor expressed by natural killer cells. It inhibits NK cell cytotoxicity and binds the ligand CLEC2D/LLT1. Browse Assay Genie's current range of KLRB1 research reagents below, or read on for the biology behind the target.
KLRB1 plays an inhibitory role in the cytotoxicity of natural killer (NK) cells. It acts as a lectin, binding the terminal carbohydrate Gal-alpha(1,3)Gal epitope and the N-acetyllactosamine epitope. It also binds CLEC2D/LLT1 as a ligand, and this interaction inhibits NK cell-mediated cytotoxicity and interferon-gamma secretion in target cells.
Activation of KLRB1 stimulates acid sphingomyelinase (SMPD1), with a marked rise in intracellular ceramide. It also stimulates the AKT1/PKB and RPS6KA1/RSK1 kinases and markedly enhances T-cell proliferation induced by anti-CD3. These signalling outputs make the receptor relevant beyond NK cells.
The KLRB1 gene encodes a protein with an extracellular domain containing several motifs characteristic of C-type lectins, a transmembrane domain and a cytoplasmic domain. Because its C terminus is external, it is classed as a type II membrane protein. It belongs to the C-type lectin superfamily, several members of which, including the rodent NKRP1 glycoprotein family, are expressed by NK cells and may help regulate NK cell function. NK cells are lymphocytes that mediate cytotoxicity and secrete cytokines after immune stimulation.
KLRB1 is also known as CD161, NKR-P1, NKR-P1A, hNKR-P1A, CLEC5B and NKR. Its previous HGNC name was killer cell lectin-like receptor subfamily B, member 1. Mouse and rat both have a Klrb1 ortholog, which is useful when planning comparative studies of CD161 biology.
KLRB1 inhibits NK cell cytotoxicity, making it a key receptor for studying how NK cell function is regulated.
KLRB1 binds Gal-alpha(1,3)Gal and N-acetyllactosamine epitopes, and the ligand CLEC2D/LLT1, supporting work on carbohydrate and protein recognition.
KLRB1 activation stimulates SMPD1, raising ceramide, and activates AKT1 and RSK1 kinases, offering a model for receptor-driven signalling.
KLRB1 activation markedly enhances anti-CD3-induced T-cell proliferation, linking this receptor to T-cell responses as well as NK biology.
KLRB1 is an inhibitory receptor on natural killer cells. It binds CLEC2D/LLT1 and inhibits NK cell-mediated cytotoxicity and interferon-gamma secretion in target cells. Its activation also stimulates acid sphingomyelinase, raising ceramide, and activates AKT1 and RSK1 kinases.
Yes. CD161 is an alias of KLRB1. Other names include NKR-P1, NKR-P1A, hNKR-P1A, CLEC5B and NKR. The previous HGNC name was killer cell lectin-like receptor subfamily B, member 1. Searching under any of these names refers to the same gene.
Yes, both mouse and rat have a Klrb1 ortholog. The rodent NKRP1 glycoprotein family belongs to the same C-type lectin superfamily and is expressed by NK cells. Check the datasheet of any product for its validated reactivity.
Ligands, signalling partners and immune-cell markers linked to KLRB1 function at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q12918; product specifications from Assay Genie datasheets.